Detalles de la búsqueda
1.
Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study.
BMC Nephrol
; 23(1): 166, 2022 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35490226
2.
Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia.
Cardiovasc Diabetol
; 20(1): 139, 2021 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34243779
3.
Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea).
Diabetes Obes Metab
; 23(2): 455-466, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118320
4.
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study.
J Med Internet Res
; 22(7): e18548, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673242
5.
Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin.
Diabetes Obes Metab
; 21(2): 227-233, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30101553
6.
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
Diabetes Obes Metab
; 20(8): 1983-1987, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29569378
7.
Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey.
J Patient Exp
; 9: 23743735221092629, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35425851
8.
Contemporary outcomes of anemia in US patients with chronic kidney disease.
Clin Kidney J
; 15(2): 244-252, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145639
9.
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials.
Adv Ther
; 39(1): 193-220, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881414
10.
Adverse clinical outcomes associated with RAAS inhibitor discontinuation: analysis of over 400 000 patients from the UK Clinical Practice Research Datalink (CPRD).
Clin Kidney J
; 14(10): 2203-2212, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804520
11.
Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China.
Int J Nephrol Renovasc Dis
; 14: 53-64, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33654421
12.
Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".
Am J Manag Care
; 25(4): 171-172, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30986013
13.
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting ß2-agonist via dry-powder inhalers and pressurized metered-dose inhalers.
Int J Chron Obstruct Pulmon Dis
; 14: 101-114, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613140
14.
Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery.
J Pain Res
; 11: 1017-1025, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29881304
15.
Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.
Am J Manag Care
; 24(8 Suppl): S156-S164, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693362
16.
Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
Am J Manag Care
; 24(8 Suppl): S138-S145, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693360
17.
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.
Am J Manag Care
; 24(8 Suppl): S146-S155, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693361
18.
Sitaxsentan for treatment of pulmonary hypertension.
Ann Pharmacother
; 41(1): 100-5, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17164394
19.
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research.
Diabetes Metab Syndr Obes
; 10: 123-139, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28435305
20.
Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease.
J Manag Care Spec Pharm
; 22(4): 326-36, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023686